1. Home
  2. ALLT vs OCGN Comparison

ALLT vs OCGN Comparison

Compare ALLT & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLT
  • OCGN
  • Stock Information
  • Founded
  • ALLT 1996
  • OCGN 2013
  • Country
  • ALLT Israel
  • OCGN United States
  • Employees
  • ALLT N/A
  • OCGN N/A
  • Industry
  • ALLT Telecommunications Equipment
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ALLT Telecommunications
  • OCGN Health Care
  • Exchange
  • ALLT Nasdaq
  • OCGN Nasdaq
  • Market Cap
  • ALLT 342.5M
  • OCGN 283.3M
  • IPO Year
  • ALLT 2006
  • OCGN N/A
  • Fundamental
  • Price
  • ALLT $7.79
  • OCGN $1.01
  • Analyst Decision
  • ALLT Buy
  • OCGN Strong Buy
  • Analyst Count
  • ALLT 1
  • OCGN 3
  • Target Price
  • ALLT N/A
  • OCGN $6.00
  • AVG Volume (30 Days)
  • ALLT 509.7K
  • OCGN 2.3M
  • Earning Date
  • ALLT 08-14-2025
  • OCGN 08-01-2025
  • Dividend Yield
  • ALLT N/A
  • OCGN N/A
  • EPS Growth
  • ALLT N/A
  • OCGN N/A
  • EPS
  • ALLT N/A
  • OCGN N/A
  • Revenue
  • ALLT $95,342,000.00
  • OCGN $4,754,000.00
  • Revenue This Year
  • ALLT $9.08
  • OCGN N/A
  • Revenue Next Year
  • ALLT $26.37
  • OCGN N/A
  • P/E Ratio
  • ALLT N/A
  • OCGN N/A
  • Revenue Growth
  • ALLT 4.74
  • OCGN N/A
  • 52 Week Low
  • ALLT $2.75
  • OCGN $0.52
  • 52 Week High
  • ALLT $10.77
  • OCGN $1.40
  • Technical
  • Relative Strength Index (RSI)
  • ALLT 51.15
  • OCGN 48.34
  • Support Level
  • ALLT $7.05
  • OCGN $0.98
  • Resistance Level
  • ALLT $8.10
  • OCGN $1.06
  • Average True Range (ATR)
  • ALLT 0.40
  • OCGN 0.05
  • MACD
  • ALLT 0.04
  • OCGN -0.00
  • Stochastic Oscillator
  • ALLT 70.48
  • OCGN 57.25

About ALLT Allot Ltd.

Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: